As of 2026-09-19, the Relative Valuation of Stoke Therapeutics Inc (STOK) is (89.38) USD. This relative valuation is based on P/E multiples. With the latest stock price at 28.93 USD, the upside of Stoke Therapeutics Inc based on Relative Valuation is -409.0%.
The range of the Relative Valuation is (78.45) - (99.14) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 23.4x - 29.7x | 26.6x |
| Forward P/E multiples | 23.5x - 30.5x | 27.0x |
| Fair Price | (78.45) - (99.14) | (89.38) |
| Upside | -371.2% - -442.7% | -409.0% |
| Date | P/E |
| 2026-09-11 | -8.70 |
| 2026-09-10 | -8.79 |
| 2026-09-09 | -8.96 |
| 2026-09-08 | -9.00 |
| 2026-09-04 | -8.93 |
| 2026-09-03 | -8.98 |
| 2026-09-02 | -9.14 |
| 2026-09-01 | -9.25 |
| 2026-08-31 | -9.35 |
| 2026-08-28 | -9.47 |
| 2026-08-27 | -9.76 |
| 2026-08-26 | -9.91 |
| 2026-08-25 | -10.02 |
| 2026-08-24 | -9.68 |
| 2026-08-21 | -9.67 |
| 2026-08-20 | -9.41 |
| 2026-08-19 | -9.89 |
| 2026-08-18 | -9.63 |
| 2026-08-17 | -9.62 |
| 2026-08-14 | -9.37 |
| 2026-08-13 | -9.38 |
| 2026-08-12 | -9.88 |
| 2026-08-11 | -9.87 |
| 2026-08-10 | -9.65 |
| 2026-08-07 | -9.80 |
| 2026-08-06 | -9.57 |
| 2026-08-05 | -9.57 |
| 2026-08-04 | -9.49 |
| 2026-08-03 | -8.86 |
| 2026-07-31 | -8.65 |
| 2026-07-30 | -9.00 |
| 2026-07-29 | -8.83 |
| 2026-07-28 | -8.80 |
| 2026-07-27 | -8.78 |
| 2026-07-24 | -8.78 |
| 2026-07-23 | -8.88 |
| 2026-07-22 | -8.68 |
| 2026-07-21 | -8.63 |
| 2026-07-20 | -8.29 |
| 2026-07-17 | -8.70 |
| 2026-07-16 | -8.72 |
| 2026-07-15 | -8.96 |
| 2026-07-14 | -8.73 |
| 2026-07-13 | -8.83 |
| 2026-07-10 | -9.40 |
| 2026-07-09 | -9.83 |
| 2026-07-08 | -9.78 |
| 2026-07-07 | -9.89 |
| 2026-07-06 | -9.71 |
| 2026-07-02 | -9.80 |